Psychotropic drugs in pregnancy: a case-control study

Area of Science:

• Obstetrics and Gynecology
• Psychiatry
• Toxicology

Background:

• Psychotropic medication use during pregnancy presents a significant clinical challenge.
• A substantial number of pregnant individuals utilize these medications for mental health conditions.

Purpose of the Study:

• To investigate the pregnancy outcomes associated with psychotropic drug exposure.
• To assess the risk of adverse events, including spontaneous abortion and congenital abnormalities, in infants exposed to psychotropic medications in utero.

Main Methods:

• A cohort study was conducted, comparing 124 pregnant women exposed to psychotropic drugs with 248 drug-naïve controls.
• Outcomes such as healthy births, pregnancy terminations, spontaneous abortions, intrauterine deaths, and premature deliveries were recorded.
• Infant development was monitored for 12 months post-birth.

Main Results:

• The psychotropic drug-exposed group showed a statistically significant increased odds ratio for spontaneous abortion (1.35; 95% CI: 1.27-11.82; P=0.02).
• Healthy babies were born to 64.5% of mothers exposed to psychotropic drugs.
• No developmental problems were observed in infants during the 12-month follow-up period.

Conclusions:

• Psychotropic drug use during pregnancy may be associated with an elevated risk of early pregnancy loss.
• The study suggests potential safety regarding infant development in the first year of life following in utero exposure.
• Further research is needed to understand the long-term effects of psychotropic medications on pregnancies and neonates.